Published in J Exp Med on September 01, 1989
Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells. Immunity (2007) 3.98
Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis. Proc Natl Acad Sci U S A (1990) 1.03
Point mutations define positions in HLA-DR3 molecules that affect antigen presentation. Proc Natl Acad Sci U S A (1990) 0.82
Transplantation of tail skin to study allogeneic CD4 T cell responses in mice. J Vis Exp (2014) 0.75
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Structure of the human class I histocompatibility antigen, HLA-A2. Nature (1987) 14.54
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature (1987) 12.43
Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J Exp Med (1981) 12.03
Binding of immunogenic peptides to Ia histocompatibility molecules. Nature (1985) 8.39
Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors. J Immunol (1989) 8.19
Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J Immunol (1985) 7.90
A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature (1988) 5.99
A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J Immunol (1981) 5.85
The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science (1987) 5.32
The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature (1988) 4.43
The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells. J Exp Med (1989) 3.30
Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J Exp Med (1977) 3.30
Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol (1977) 3.13
B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J Exp Med (1979) 2.28
T cells can distinguish between allogeneic major histocompatibility complex products on different cell types. Nature (1988) 2.21
The T cell receptor V beta 6 domain imparts reactivity to the Mls-1a antigen. Cell Immunol (1989) 2.03
Allele-specific control of Ia molecule surface expression and conformation: implications for a general model of Ia structure-function relationships. Proc Natl Acad Sci U S A (1987) 1.67
Gene conversion between murine class II major histocompatibility complex loci. Functional and molecular evidence from the bm 12 mutant. J Exp Med (1984) 1.66
Ir gene function in an I-A subregion mutant B6.C-H-2bm12. J Exp Med (1981) 1.51
Structure-function analysis of the Abm12 beta mutation using site-directed mutagenesis and DNA-mediated gene transfer. J Immunol (1987) 1.43
Selective loss of antigen-specific Ir gene function in IA mutant B6.C-H-2bm12 is an antigen presenting cell defect. Proc Natl Acad Sci U S A (1981) 1.40
Functionally distinct subsites on a class II major histocompatibility complex molecule. Nature (1987) 1.36
Molecular genetic analysis of 178 I-Abm12-reactive T cells. J Exp Med (1989) 1.36
Analysis of the expression and function of class-II major histocompatibility complex-encoded molecules by DNA-mediated gene transfer. Annu Rev Immunol (1986) 1.33
Identification of functional regions on the I-Ab molecule by site-directed mutagenesis. Proc Natl Acad Sci U S A (1986) 1.24
I-A-restricted T cell antigen recognition. Analysis of the roles of A alpha and A beta using DNA-mediated gene transfer. J Exp Med (1986) 1.05
In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med (1997) 6.53
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity (1997) 5.44
An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1988) 4.72
IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol (1993) 4.65
Stimulation of a major subset of lymphocytes expressing T cell receptor gamma delta by an antigen derived from Mycobacterium tuberculosis. Cell (1989) 4.53
Immunology. The ins and outs of antigen processing and presentation. Nature (1986) 4.08
A single major pathway of T-lymphocyte interactions in antigen-specific immune suppression. Scand J Immunol (1981) 3.85
Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid. Proc Natl Acad Sci U S A (1983) 3.66
The immune response genes of the major histocompatibility complex. Immunol Rev (1978) 3.61
Development of the nursing section of the community health team. Br Med J (1968) 3.40
Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (1995) 3.40
The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells. J Exp Med (1989) 3.30
Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors. J Exp Med (1980) 3.21
Experimental lepromatous leprosy. Nature (1967) 3.18
Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature (1990) 3.15
Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol (2001) 2.93
Primary structure of human T-cell receptor alpha-chain. Nature (1985) 2.93
Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J Exp Med (1998) 2.84
The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med (2000) 2.80
Phenotypic suppression of nonsense mutants in yeast by aminoglycoside antibiotics. Nature (1979) 2.66
Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. N Engl J Med (1985) 2.62
An endogenous retrovirus mediating deletion of alpha beta T cells? Nature (1991) 2.57
Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J Exp Med (1986) 2.55
Mls--a retrovirus exploits the immune system. Immunol Today (1991) 2.54
Y-encoded, species-specific DNA in mice: evidence that the Y chromosome exists in two polymorphic forms in inbred strains. Cell (1984) 2.53
A novel lymphocyte function-associated antigen (LFA-1): cellular distribution, quantitative expression, and structure. J Immunol (1981) 2.52
Shared idiotypic determinants on antibodies and T-cell-derived suppressor factor specific for the random terpolymer L-glutamic acid60-L-alanine30-L-tyrosine10. J Exp Med (1979) 2.51
Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells. J Exp Med (1979) 2.40
Characterization of T cell receptor gamma chain expression in a subset of murine thymocytes. Science (1986) 2.40
A role for peptide in determining MHC class II structure. Nature (1991) 2.32
A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. Science (1989) 2.32
Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J Exp Med (1993) 2.27
Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med (2000) 2.25
Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells. Science (1990) 2.25
Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med (1995) 2.24
Inhibition of cell-mediated cytolysis of trinitrophenyl-derivatized target cells by alloantisera directed to the products of the K and D loci of the H-2 complex. Proc Natl Acad Sci U S A (1976) 2.20
Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin. Immunity (2001) 2.17
Rearrangement of T-cell receptor beta-chain genes during T-cell development. Proc Natl Acad Sci U S A (1985) 2.13
Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc Natl Acad Sci U S A (1997) 2.13
Specific antigen-Ia activation of transfected human T cells expressing murine Ti alpha beta-human T3 receptor complexes. Nature (1987) 2.11
Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. V. Role of idiotypes in the suppressor pathway. J Exp Med (1980) 2.11
The proteins of enveloped and deenveloped equine abortion (herpes) virus and the separated envelope. Virology (1971) 2.10
Murine I-A beta chain polymorphism: nucleotide sequences of three allelic I-A beta genes. Science (1983) 2.04
The T cell receptor V beta 6 domain imparts reactivity to the Mls-1a antigen. Cell Immunol (1989) 2.03
The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity (2001) 2.02
Nucleotide sequence and expression of a mouse interleukin 2 receptor cDNA. J Immunol (1985) 2.00
The T cell receptor: the alpha and beta chains define idiotype, and antigen and MHC specificity. Cell (1985) 1.96
MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature (1992) 1.95
Information transfer at the immunological synapse. Curr Biol (2001) 1.95
CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J Immunol (2000) 1.94
"Exon-shuffling" maps control of antibody- and T-cell-recognition sites to the NH2-terminal domain of the class II major histocompatibility polypeptide A beta. Proc Natl Acad Sci U S A (1985) 1.93
Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant. Science (1992) 1.89
Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells. J Exp Med (1997) 1.87
Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor. J Exp Med (1975) 1.86
Unexpectedly complex regulation of CD4/CD8 coreceptor expression supports a revised model for CD4+CD8+ thymocyte differentiation. Immunity (1996) 1.83
Rearrangement and transcription of a T-cell receptor beta-chain gene in different T-cell subsets. Proc Natl Acad Sci U S A (1985) 1.78
Influence of allelic polymorphism on the assembly and surface expression of class II MHC (Ia) molecules. Cell (1985) 1.78
Limited receptor repertoire in a mycobacteria-reactive subset of gamma delta T lymphocytes. Nature (1989) 1.77
CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production. J Exp Med (1994) 1.76
Thy-1 functions as a signal transduction molecule in T lymphocytes and transfected B lymphocytes. Nature (1986) 1.76
A role for clonal inactivation in T cell tolerance to Mls-1a. Nature (1990) 1.75
Helper and suppressor T cell factors. Springer Semin Immunopathol (1980) 1.74
Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells. J Exp Med (1976) 1.74
A third T-cell receptor beta-chain variable region gene encodes reactivity to Mls-1a gene products. Proc Natl Acad Sci U S A (1989) 1.68
R factor proteins synthesized in Escherichia coli minicells: membrane-associated R factor proteins. J Bacteriol (1974) 1.67
The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J Exp Med (1994) 1.67
Allele-specific control of Ia molecule surface expression and conformation: implications for a general model of Ia structure-function relationships. Proc Natl Acad Sci U S A (1987) 1.67
Molecular basis for the nonexpression of V beta 17 in some strains of mice. J Immunol (1988) 1.66
A motif in the alphabeta T-cell receptor controls positive selection by modulating ERK activity. Nature (2000) 1.65
Membrane Ia expression and antigen-presenting accessory cell function of L cells transfected with class II major histocompatibility complex genes. J Exp Med (1984) 1.65
The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice. J Exp Med (1987) 1.64
Characterization of a rat monoclonal antibody specific for a determinant encoded by the V beta 7 gene segment. Depletion of V beta 7+ T cells in mice with Mls-1a haplotype. J Immunol (1990) 1.64
Divergent changes in the sensitivity of maturing T cells to structurally related ligands underlies formation of a useful T cell repertoire. Immunity (1999) 1.64
Quantitative impact of thymic clonal deletion on the T cell repertoire. J Exp Med (1997) 1.64
Open donor, laparoscopic donor and hand assisted laparoscopic donor nephrectomy: a comparison of outcomes. J Urol (2001) 1.62
An analysis of T-cell receptor variable region gene expression in major histocompatibility complex disparate mice. Proc Natl Acad Sci U S A (1988) 1.62
Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science (1991) 1.61
Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity (1995) 1.61
Preferential positive selection of V alpha 2+ CD8+ T cells in mouse strains expressing both H-2k and T cell receptor V alpha a haplotypes: determination with a V alpha 2-specific monoclonal antibody. Eur J Immunol (1992) 1.58
Expression of genes of the T-cell antigen receptor complex in precursor thymocytes. Nature (1985) 1.57
Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J Exp Med (1993) 1.56
Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents. J Natl Cancer Inst (1975) 1.55
The T cell repertoire may be biased in favor of MHC recognition. Cell (1986) 1.55
CD4+ T cell survival is not directly linked to self-MHC-induced TCR signaling. Nat Immunol (2000) 1.54
An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself. J Exp Med (1990) 1.54
T-cell recognition of a chimaeric class II/class I MHC molecule and the role of L3T4. Nature (1985) 1.53
Class I and class II MHC gene products differentially affect the fate of V beta 5 bearing thymocytes. J Mol Cell Immunol (1990) 1.50
Polymorphism and complexity of the human DC and murine I-A alpha chain genes. EMBO J (1983) 1.50
MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature (1994) 1.50
Extensive polymorphism surrounding the murine Ia A beta chain gene. J Immunol (1983) 1.49
The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate. Nature (2000) 1.49
Misreading of the ribosomal suppressor SUP46 due to an altered 40 S subunit in yeast. J Mol Biol (1981) 1.49
Accessory cell stimulation of T cell proliferation requires active antigen processing, Ia-restricted antigen presentation, and a separate nonspecific 2nd signal. J Immunol (1981) 1.48
Essential role of CD8 palmitoylation in CD8 coreceptor function. J Immunol (2000) 1.46